Page 242 - Academic Press Encyclopedia of Physical Science and Technology 3rd BioTechnology
P. 242

P1: GTV/GWT  P2: GRB/GJP  QC: FYDFinal Pages
 Encyclopedia of Physical Science and Technology  EN011J-559  July 25, 2001  18:57






               820                                                                                   Pharmacokinetics


               Hebbard, G. S., Sun, W. M., Bochner, F., and Horowitz, M. (1995).  ical pharmacokinetic considerations,” Clin. Pharmacokinet. 10, 404–
                 “Pharmacokinetic considerations in gastrointestinal motor disorders,”  426.
                 Clin. Pharmacokinet. 28, 41–66.                 Peck, C. (1985). “Bedside Clinical Pharmacokinetics,” Pharmacometrics
               Holford, N. H. G. (1996). “A standard size for pharmacokinetics,” Clin.  Press, Rockville, MD.
                 Pharmacokinet. 30, 329–332.                     Reetze-Bonorden, P., Bohler, J., and Keller, E. (1993). “Drug dosage in
               James, W. P. T. (1976). “Research on Obesity,” Her Majesty’s Stationery  patients during continuous renal replacement therapy,” Clin. Pharma-
                 Office, London.                                    cokinet. 24, 362–379.
               Kalant, H., and Roschlau, W. (eds.). (1998). “Principles of Medical Phar-  Schwartz, M. L. (1974). “Antiarrhythmic effectiveness of intramuscu-
                 macology,” 6th ed., Oxford University Press, Oxford.  lar lidocaine: Influence of different injection sites,” Clin. Pharmacol.
               Leving, R. R. (2000). “Pharmacology: Drug Actions and Reactions,” 6th  Ther. 14, 77.
                 ed., Parthenon, New York.                       Shammas, F. V., and Dickstein, K. (1988). “Clinical pharmacokinetics
               Morgan, D. J., and Bray, K. M. (1994). “Lean body mass as a predictor  in heart failure,” Clin. Pharmacokinet. 15, 94–113.
                 of drug dosage. Implications for drug therapy,” Clin. Pharmacokinet.  Wagner, J. G. (1971). “Biopharmaceutics and Relevant Pharmacokinet-
                 26, 292–307.                                      ics,” Drug Intelligence Publications, Hamilton, IL.
               Morgan, D. J., and McLean, A. J. (1995). “Clinical pharmacokinetic and  Ward, R. M. (1995). “Pharmacological treatment of the fetus,” Clin.
                 pharmacodynamic considerations in patients with liver disease,” Clin.  Pharmacokinet. 28, 342–350.
                 Pharmacokinet. 29, 370–391.                     Woodhouse, K. W., and Wynne, H. A. (1988). “Age-related changes in
               Paton, T. W., Cornish, W. R., Manuel, M. A., and Hardy, B. G.  liver size and hepatic blood flow: The influence of drug metabolism
                 (1985). “Drug therapy in patients undergoing peritoneal dialysis: Clin-  in the elderly,” Clin. Pharmacokinet. 15, 287–294.
   237   238   239   240   241   242   243   244   245   246   247